Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
The American Journal of Managed Care|March 6, 2015
Predicting nursing home placement among home- and community-based services program participantsMelissa A Greiner, Laura G Qualls, Isao Iwata, et al.
Journal of Medicinal Chemistry|July 30, 2008
Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functionsFrancesco Gentili, Claudia Cardinaletti, Cristian Vesprini, et al.
European Journal of Medicinal Chemistry|April 1, 2016
Transfer of SAR information from hypotensive indazole to indole derivatives acting at α-adrenergic receptors: In vitro and in vivo studiesJaroslaw Sączewski, Alan Hudson, Mika Scheinin, et al.
Bioorganic & Medicinal Chemistry|December 17, 2011
Synthesis and biological activities of 2-[(heteroaryl)methyl]imidazolinesJaroslaw Saczewski, Alan Hudson, Mika Scheinin, et al.
Journal of Medicinal Chemistry|March 23, 2013
Discovery and structure-activity relationships of pyrrolone antimalarialsDinakaran Murugesan, Alka Mital, Marcel Kaiser, et al.
Human Molecular Genetics|January 13, 2006
Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regenerationGisela Melcon, Serguei Kozlov, Dedra A Cutler, et al.
Systematic Reviews|December 16, 2014
Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesisMichael G Wilson, Moriah E Ellen, John N Lavis, et al.
BMC Nephrology|April 4, 2018
Effects of dialysate to serum sodium (Na<sup>+</sup>) alignment in chronic hemodialysis (HD) patients: retrospective cohort study from a quality improvement projectJochen G Raimann, Linda H Ficociello, Len A Usvyat, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2004
Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient miceLoren G Fong, Jennifer K Ng, Margarita Meta, et al.
Bioorganic & Medicinal Chemistry|August 31, 2010
Novel imidazoline compounds as partial or full agonists of D2-like dopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFIGianfabio Giorgioni, Dario Ambrosini, Cristian Vesprini, et al.
Pageof 7